Showing results (11-20 of 46) with videos related to
Sort By:
Pageof 5
The World Allergy Organization Journal|November 5, 2013
Insights, attitudes, and perceptions about asthma and its treatment: findings from a multinational survey of patients from Latin AmericaJorge F Maspero, Jose R Jardim, Alvaro Aranda, et al.Journal of Asthma and Allergy|April 7, 2023
Clinical Efficacy among Patients with Chronic Rhinosinusitis with Nasal Polyps and Clinical Features of Obstructive Lung Disease: Post Hoc Analysis of the Phase III SINUS-24 and SINUS-52 StudiesJorge F Maspero, Claus Bachert, Fernando J Martinez, et al.The Journal of Allergy and Clinical Immunology. in Practice|June 28, 2015
Taking Aim at Asthma Around the World: Global Results of the Asthma Insight and Management Survey in the Asia-Pacific Region, Latin America, Europe, Canada, and the United StatesRobert A Nathan, Philip J Thompson, David Price, et al.Respiratory Medicine|March 11, 2023
Efficacy of once-daily, single-inhaler, fixed-dose combination of mometasone/indacaterol/glycopyrronium in patients with asthma with or without persistent airflow limitation: Post hoc analysis from the IRIDIUM studyRichard N Van Zyl-Smit, Huib Am Kerstjens, Jorge F Maspero, et al.The Lancet. Respiratory Medicine|April 5, 2026
Rilzabrutinib for patients with moderate-to-severe asthma with uncontrolled symptoms: a double-blind, placebo-controlled, phase 2 studyJorge F Maspero, Ian D Pavord, Michael E Wechsler, et al.The European Respiratory Journal|July 16, 2021
Effect of exacerbation history on clinical response to dupilumab in moderate-to-severe uncontrolled asthmaJonathan Corren, Constance H Katelaris, Mario Castro, et al.Respiratory Medicine|September 2, 2023
Dupilumab efficacy in high sleep disturbance management among patients with type 2 asthmaJorge F Maspero, Shirin Shafazand, Jeremy Cole, et al.The Journal of Allergy and Clinical Immunology. in Practice|August 29, 2024
Dupilumab Efficacy in Children With Type 2 Asthma Receiving High- to Medium-Dose Inhaled Corticosteroids (VOYAGE)Jorge F Maspero, Martti A Antila, Antoine Deschildre, et al.Allergy|August 30, 2021
Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trialsJoaquim Mullol, Tanya M Laidlaw, Claus Bachert, et al.ERJ Open Research|October 20, 2023
Impact of exacerbation history on long-term efficacy of dupilumab in patients with asthmaJonathan Corren, Constance H Katelaris, Mario Castro, et al.Pageof 5